Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Indian pharma’s global presence in generic medicine exports among others like biosimilars will indicate a strategic shift towards further expansion in the international markets particularly the US. To ...

The Ministry of Economy, Trade and Industry (METI), jointly with the Financial Services Agency (FSA) and the Ministry of the Environment (MOE), has held repeated meetings of the Study Group for ...

Accelerated formulation strategies are a useful tool to reduce development timelines and cost, but key priorities must be considered early on to ensure success. Although approximations vary ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. For the pharmaceutical industry ...

The process usually takes between 14 and 18 months from publishing the final scope on the NICE website to approval of the final guidance by the NICE Guidance Executive (see chapter 10). The time taken ...

Stay ahead in the rapidly evolving LNP space with the 4 th LNP Formulation & Process Development Summit—the largest global meeting dedicated purely to LNPs. The official event guide is your must-have ...

Nov 21 (Reuters) - U.S. Food and Drug Administration: * Says issued final guidance to assist the industry in their development of generic versions of approved abuse-deterrent formulation opioids‍ Sign ...

This is not the current manual. From January 2015, guidelines were developed using Developing NICE guidelines: the manual. The National Institute for Health and Clinical Excellence (NICE) is the ...